Food Safety Incidents

Suggestion of therapeutic benefits has been detected in Supplement the food in g notes insufree.

Written by SGS Digicomply Editorial Team | Feb 27, 2026 11:00:00 PM

Incident Overview

On February 12, 2026, a significant food safety incident was reported concerning a dietary supplement identified as "Supplement the food in g notes insufree." This incident was flagged by the Brazilian Health Regulatory Agency, known as ANVISA, due to concerns regarding the suggestion of therapeutic benefits associated with the product.

Details of the Incident

The origin of the issue is traced back to Brazil, where the supplement was being marketed. The incident falls under the category of control, indicating that regulatory measures are being considered or implemented to address the potential risks associated with the product.

Health Implications

The suggestion of therapeutic benefits in dietary supplements can pose significant health risks to consumers. Such claims may lead individuals to rely on the supplement for health improvements without sufficient scientific backing. This can result in neglecting conventional medical treatments or therapies that are proven to be effective.

Regulatory Response

In response to this incident, it is crucial for regulatory bodies to conduct thorough investigations into the claims made by the supplement. Consumers are advised to exercise caution and consult healthcare professionals before using any dietary supplements that claim to offer therapeutic benefits.

Conclusion

As the situation develops, it is essential to stay informed about the findings from health authorities and to prioritize safety when considering dietary supplements. The incident underscores the importance of regulatory oversight in ensuring that food products, including dietary supplements, are safe for public consumption.

  • Incident: Suggestion of therapeutic benefits has been detected in Supplement the food in g notes insufree.
  • Date: 2026-02-12
  • Product: Supplement the food in g notes insufree
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: Brazil
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Control
  • Source: Brazilian Health Regulatory Agency - ANVISA